<DOC>
	<DOCNO>NCT02424175</DOCNO>
	<brief_summary>This open-label single-arm pilot study measure microbiological clinical impact Fecal Microbiota Transplantation ( FMT ) patient Primary Sclerosing Cholangitis ( PSC ) . The investigator prospectively enroll 10 PSC patient Stage 1 2 also concurrent inflammatory bowel disease Donor Stool one healthy donor obtain OpenBiome . OpenBiome nonprofit 501 ( c ) ( 3 ) organization provide hospital screen , filter , frozen material ready clinical use</brief_summary>
	<brief_title>Fecal Microbiota Transplantation Treatment Primary Sclerosing Cholangitis .</brief_title>
	<detailed_description />
	<mesh_term>Cholangitis</mesh_term>
	<mesh_term>Cholangitis , Sclerosing</mesh_term>
	<criteria>1 . Age 18 old 2 . Confirmed diagnosis PSC ( concurrent diagnosis inflammatory bowel disease ) characterize cholestatic liver condition great 6 month duration confirmatory cholangiographic finding , well elevation serum alkaline phosphatase great 1.5 time upper limit normal . 1 . Decompensated liver disease 2 . Patients pregnant breastfeed 3 . Use concomitant immune modulators include methotrexate , mycophenolate mofetil , tacrolimus , cyclosporine , thalidomide , Interleukin10 , Interleukin11 within 4 week prior receive FMT 4 . Patients unable give inform consent 5 . Patients unable unwilling undergo colonoscopy moderate sedation ( &gt; ASA class II ) 6 . Patients previously undergone FMT Patients confirm malignancy cancer 7 . Patients immunocompromised 8 . Treatment within last 8 week infliximab , adalimumab , certolizumab , natalizumab , vedolizumab thalidomide 9 . Antibiotic use within 2months start date 10 . Participation clinical trial precede 30 day simultaneously trial 11 . Probiotic use within 30 day start date 12 . Congenital acquire immunodeficiency 13 . Other comorbidities include : Diabetes mellitus , cancer , systemic lupus , must able tolerate conscious sedation colonoscopy 14 . Chronic kidney disease define GFR &lt; 60mL/min/1.73m2 44 15 . History rheumatic heart disease , endocarditis , valvular disease due risk bacteremia colonoscopy 16 . Steroid dose &gt; 20mg/day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Fecal Transplant</keyword>
	<keyword>Primary Sclerosing Cholangitis</keyword>
	<keyword>Fecal Microbiota Transplantation</keyword>
</DOC>